Vanguard Personalized Indexing Management
BMRN icon

Vanguard Personalized Indexing Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$952K Buy
16,631
+4,081
+33% +$224K 0.01% 1026
2026
Q1 		$709K Buy
12,550
+2,345
+23% +$137K 0.01% 1101
2025
Q4 		$606K Sell
10,205
-2,877
-22% -$157K 0.01% 1155
2025
Q3 		$709K Sell
13,082
-911
-7% -$52.1K 0.01% 1073
2025
Q2 		$769K Sell
13,993
-10,433
-43% -$614K 0.01% 1004
2025
Q1 		$1.73M Buy
24,426
+2,550
+12% +$172K 0.03% 547
2024
Q4 		$1.44M Buy
21,876
+4,888
+29% +$327K 0.02% 604
2024
Q3 		$1.19M Buy
16,988
+6,357
+60% +$531K 0.02% 685
2024
Q2 		$875K Buy
10,631
+1,356
+15% +$113K 0.02% 741
2024
Q1 		$810K Sell
9,275
-26
-0.3% -$2.33K 0.02% 767
2023
Q4 		$897K Sell
9,301
-1,565
-14% -$138K 0.02% 716
2023
Q3 		$961K Sell
10,866
-850
-7% -$75.6K 0.03% 576
2023
Q2 		$1.02M Buy
11,716
+436
+4% +$41K 0.03% 559
2023
Q1 		$1.1M Sell
11,280
-184
-2% -$19.1K 0.04% 485
2022
Q4 		$1.19M Sell
11,464
-126
-1% -$11.8K 0.05% 442
2022
Q3 		$982K Buy
11,590
+2,472
+27% +$220K 0.04% 486
2022
Q2 		$756K Buy
9,118
+5,111
+128% +$407K 0.04% 603
2022
Q1 		$309K Sell
4,007
-4
-0.1% -$335 0.02% 990
2021
Q4 		$354K Buy
+4,011
New +$331K 0.02% 819
2021
Q3 		– Sell
-4,294
Closed -$358K – 986
2021
Q2 		$358K Buy
+4,294
New +$340K 0.04% 656

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Personalized Indexing Management's BMRN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its BioMarin Pharmaceuticals (BMRN) stake by 33% in Q2 2026, buying an estimated $224K and bringing the position to 16,631 shares worth $952K. The position accounts for 0.01% of the portfolio, ranked #1026.

Vanguard Personalized Indexing Management first reported a position in BMRN in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.73M in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 16,631 shares of BioMarin Pharmaceuticals worth $952K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 4,081 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $224K.
  • BioMarin Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1026 holding.
  • Vanguard Personalized Indexing Management first reported a position in BioMarin Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Vanguard Personalized Indexing Management's BioMarin Pharmaceuticals position peaked at $1.73M in Q1 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.